Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis [20]

Leukemia

Volumn 20, Issue 12, 2006, Pages 2217-2218

  Ledda, Antonio ^a   Caocci, G ^a   Spinicci, G ^b   Cocco, E ^b   Mamusa, E ^b   La Nasa, G ^a  

^a Binaghi Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IDARUBICIN; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID; THYMOCYTE ANTIBODY;

ADULT; ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME TRANSLOCATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GINGIVA BLEEDING; HEPATOSPLENOMEGALY; HUMAN; HYPERHIDROSIS; IMMUNOPHENOTYPING; LETTER; LEUKEMIA REMISSION; LEUKOPENIA; MULTIPLE SCLEROSIS; PALLOR; PETECHIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; STEM CELL MOBILIZATION; THROMBOCYTOPENIA;

EID: 33751254778     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404443     Document Type: Letter

References (9)

1. Brunning RD, Matutes E, Flandrin G, Vardiman J, Bennet J, Head D et al. Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC press: Lyon, 2001, pp 89-91.
2. Vicari AM, Ciceri F, Folli F, Lanzi R, Colombo B, Comi G et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia 1998; 12: 441-442.
3. Cattaneo C, Almici C, Borlenghi E, Motta M, Rossi G. A case of acute promyelocytic leukemia following mitoxantrone treatment of multiple sclerosis. Leukemia 2003; 17: 986-987.
4. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003; 11: 2123-2137.
5. Novoselac AV, Reddy S, Sanmugarajah J. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia 2004; 18: 1561-1562.
6. Arruda OW, Montú MB, de Oliveira Mde S, Ramina R. Acute myeloid leukaemia induced by mitoxantrone. Arq Neuropsiquiatr 2005; 63: 327-329.
7. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. GIMEMA and AIEOP Cooperative Groups. Blood 1997; 90: 1014-1021.
8. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005; 352: 1529-1538.
9. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: Impact on disease activity and quality of life. Blood 2005; 105: 2601-2607.